LiBBY Trial Results: THC/CBD Reduced Agitation in Late-Stage Dementia
A specific THC/CBD formulation significantly reduced agitation in hospice-eligible people with advanced dementia during a 12-week Phase 2 trial.
A specific THC/CBD formulation significantly reduced agitation in hospice-eligible people with advanced dementia during a 12-week Phase 2 trial.